NSN 6505-01-517-1139 · NIIN 015171139 · FSC 6505
NO DASHES 6505015171139
In Stock
BIMATOPROST OPHTHALMIC SOLUTION
Drugs and Biologicals
Technical characteristics
3 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LUMIGAN, BIMATOPROST OPHTHALMIC SOLUTION, 0.03 PCT |
| FEAT | SPECIAL FEATURES | DOES NOT REQUIRE REFRIGERATION; AVAILABLE IN 2.5 ML AND 5 ML SIZES; HAS BEEN REPORTED TO CAUSE CHANGES TO PIGMENTED TISSUES; INCLUDING INCREASED PIGMENTATION AND GROWTH OF EYELASHES AND INCREASED PIGMENTATION OF THE IRIS AND PERIORBITAL TISSUE, EYELID, CHANGES MAY BE PERMANENT |
| FTLD | FUNCTIONAL DESCRIPTION | IS INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE, IOP, IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION WHO ARE INTOLERANT OF OTHER IOP-LOWERING MEDICATIONS OR INSUFFICIENTLY RESPONSIVE TO ANOTHER IOP LOWERING MEDICATION; PROVIDES POWERFUL IOP REDUCTION THAT REMAINS CONSISTENT OVER TIME, BOTH IN NUMBER OF PATIENTS ACHIEVING LOW TARGET PRESSURE AND OVERALL PERCENTAGE REDUCTION |